Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

HIV & AIDS Health Center

Font Size

Vaginal Gel Cuts Women's HIV Risk

For First Time, Vaginal Gel Shown to Protect Against HIV From Sex
WebMD Health News
Reviewed by Louise Chang, MD

Feb. 10, 2009 -- For the first time, a woman-controlled product -- the PRO 2000 vaginal gel -- has been shown to protect women from getting HIV during sex.

Protection is far from complete: The gel cuts HIV risk by 30% -- or by 36%, if women who went off the gel during a pregnancy are excluded.

But it's the first real success after a frustrating string of failures with other products that promised to give women the means to protect themselves against getting HIV from a male sex partner.

"The study, while not conclusive, provides a glimmer of hope to millions of women at risk for HIV, especially young women in Africa," study leader Salim S. Abdool Karim, PhD, MBChB, director of South Africa's AIDS research center, says in a news release.

Karim and colleagues enrolled more than 3,000 sexually active women from the U.S., Malawi, South Africa, Zambia, and Zimbabwe. Some of the women used the PRO 2000 product, which blocks the cellular doorway HIV uses to enter cells.

Other women used the BufferGel product, which was not effective. The two active gels were compared to no gel or to a placebo gel.

Importantly, there were no significant safety issues with the gel. There were 36 HIV infections among women using PRO 2000 -- fewer than the 54 HIV infections among BufferGel users, the 51 HIV infections among placebo users, and 53 HIV infections among women using no gel.

Women in the study were encouraged to have their partners wear condoms during sex and were provided condoms for this purpose.

Although condom use was high, women who used the gel reported less condom use by their partners. That's troubling. It's a signal that overconfidence in protective gels might reduce use of a much more reliable means of preventing HIV transmission.

The NIH-sponsored trial did not prove PRO 2000 effective. That will be up to a larger, U.K.-sponsored trial involving nearly 9,400 women in Africa. That study should be finished by the end of the summer.

Karim reported the findings at this week's annual Conference on Retroviruses and Opportunistic Infections in Montreal.

Today on WebMD

How much do you know?
contemplative man
What to do now.
Should you be tested?
HIV under microscope
What does it mean?
HIV AIDS Screening
man opening condom wrapper
HIV AIDS Treatment
Discrimination Stigma
Treatment Side Effects
grilled chicken and vegetables
obese man standing on scale
cold sore